Cargando…
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
Gastric cancer is a heterogeneous disease with diverse histological and genomic subtypes, making it difficult to demonstrate treatment efficacy in clinical trials. However, recent efforts have been made to identify molecular biomarkers with prognostic and predictive implications to better understand...
Autores principales: | Sato, Yasushi, Okamoto, Koichi, Kawano, Yutaka, Kasai, Akinari, Kawaguchi, Tomoyuki, Sagawa, Tamotsu, Sogabe, Masahiro, Miyamoto, Hiroshi, Takayama, Tetsuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380533/ https://www.ncbi.nlm.nih.gov/pubmed/37510761 http://dx.doi.org/10.3390/jcm12144646 |
Ejemplares similares
-
Overview of Chemotherapy for Gastric Cancer
por: Sato, Yasushi, et al.
Publicado: (2023) -
Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives
por: Sato, Yasushi, et al.
Publicado: (2022) -
Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer
por: Sagawa, Tamotsu, et al.
Publicado: (2023) -
Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report
por: Sagawa, Tamotsu, et al.
Publicado: (2023) -
Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab
por: Sagawa, Tamotsu, et al.
Publicado: (2020)